Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2002 8
2003 14
2004 13
2005 14
2006 16
2007 18
2008 15
2009 29
2010 29
2011 34
2012 51
2013 55
2014 60
2015 93
2016 94
2017 94
2018 97
2019 129
2020 137
2021 123
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

1,008 results
Results by year
Filters applied: . Clear all
Page 1
COPD: preclinical models and emerging therapeutic targets.
Barreiro E, Wang X, Tang J. Barreiro E, et al. Among authors: tang j. Expert Opin Ther Targets. 2019 Oct;23(10):829-838. doi: 10.1080/14728222.2019.1667976. Epub 2019 Sep 20. Expert Opin Ther Targets. 2019. PMID: 31512957 Review.
Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.
Seijkens TTP, van Tiel CM, Kusters PJH, Atzler D, Soehnlein O, Zarzycka B, Aarts SABM, Lameijer M, Gijbels MJ, Beckers L, den Toom M, Slütter B, Kuiper J, Duchene J, Aslani M, Megens RTA, van 't Veer C, Kooij G, Schrijver R, Hoeksema MA, Boon L, Fay F, Tang J, Baxter S, Jongejan A, Moerland PD, Vriend G, Bleijlevens B, Fisher EA, Duivenvoorden R, Gerdes N, de Winther MPJ, Nicolaes GA, Mulder WJM, Weber C, Lutgens E. Seijkens TTP, et al. Among authors: tang j. J Am Coll Cardiol. 2018 Feb 6;71(5):527-542. doi: 10.1016/j.jacc.2017.11.055. J Am Coll Cardiol. 2018. PMID: 29406859 Free PMC article.
CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Nie L, Wei Y, Zhang F, Hsu YH, Chan LC, Xia W, Ke B, Zhu C, Deng R, Tang J, Yao J, Chu YY, Zhao X, Han Y, Hou J, Huo L, Ko HW, Lin WC, Yamaguchi H, Hsu JM, Yang Y, Pan DN, Hsu JL, Kleer CG, Davidson NE, Hortobagyi GN, Hung MC. Nie L, et al. Among authors: tang j. Nat Commun. 2019 Nov 8;10(1):5114. doi: 10.1038/s41467-019-13105-5. Nat Commun. 2019. PMID: 31704972 Free PMC article.
Immuno-oncology drug development goes global.
Xin Yu J, Hubbard-Lucey VM, Tang J. Xin Yu J, et al. Among authors: tang j. Nat Rev Drug Discov. 2019 Nov;18(12):899-900. doi: 10.1038/d41573-019-00167-9. Nat Rev Drug Discov. 2019. PMID: 31780841 No abstract available.
TGF-β induces ST2 and programs ILC2 development.
Wang L, Tang J, Yang X, Zanvit P, Cui K, Ku WL, Jin W, Zhang D, Goldberg N, Cain A, Ni B, Zhao K, Wu Y, Chen W. Wang L, et al. Among authors: tang j. Nat Commun. 2020 Jan 7;11(1):35. doi: 10.1038/s41467-019-13734-w. Nat Commun. 2020. PMID: 31911623 Free PMC article.
Trends in clinical development for PD-1/PD-L1 inhibitors.
Xin Yu J, Hodge JP, Oliva C, Neftelinov ST, Hubbard-Lucey VM, Tang J. Xin Yu J, et al. Among authors: tang j. Nat Rev Drug Discov. 2020 Mar;19(3):163-164. doi: 10.1038/d41573-019-00182-w. Nat Rev Drug Discov. 2020. PMID: 32127660 No abstract available.
1,008 results